Yahoo

Mail

La bourse est fermée

Dow Jones
38 084,61
-301,48(-0,79 %)
Nasdaq
15 860,03
-123,06(-0,77 %)
Nikkei 225
38 405,66
+470,90(+1,24 %)
EUR/USD
1,0683
-0,0042(-0,40 %)
HANG SENG
17 763,03
+16,12(+0,09 %)
Bitcoin EUR
58 726,11
-631,68(-1,06 %)

NovaBay Pharmaceuticals, Inc. (NBY)

NYSE American - Nasdaq Cours en temps réel. Devise en USD

Ajouter à la liste dynamique

0,0807

-0,0023

(-2,77 %)

À partir de 12:20PM EDT. Marché ouvert.

Détenteurs principaux

Effectif d’initiés

Transactions d’initiés

Devise en USD

Achat d’initiés au cours des 6 derniers mois	Titres	Trans.
Achats	0	0
Ventes	S.O.	0
Titres nets achetés (vendus)	0	0
Total des titres d’initiés détenus	9,33k	S.O.
% des titres nets acquis (vendus)	S.O.	S.O.

Achats institutionnels nets à partir du trimestre précédent jusqu’au dernier trimestre	Titres
Titres nets achetés (vendus)	S.O.
% de variation dans les titres institutionnels détenus	S.O.

Transactions d’initiés rapportées - Deux dernières années

Initié	Transaction	Type	Valeur	Date	Titres
FREIMAN PAUL EDWARD Director		Direct		11 mai 2023	858
ZHENG JEFF YENYOU Director		Direct		11 mai 2023	858
WU MIJIA Director		Direct		11 mai 2023	858
GARLIKOV JULIE Director		Direct		11 mai 2023	858
SIT SWAN Director		Direct		11 mai 2023	858
ZHENG YONGXIANG Director		Direct		11 mai 2023	858
KUNIN JEFFREY Officer	Sale at price 1.81 per share.	Indirect	2	06 déc. 2022	1
KUNIN AUDREY Officer	Sale at price 1.81 per share.	Indirect	2	06 déc. 2022	1
KUNIN JEFFREY Officer	Sale at price 2.10 per share.	Indirect	12 545	21 nov. 2022	5 960
KUNIN JEFFREY Officer	Sale at price 2.10 per share.	Indirect	12 545	21 nov. 2022	5 960
KUNIN AUDREY Officer and Director	Sale at price 2.10 per share.	Indirect	12 545	21 nov. 2022	5 960
KUNIN AUDREY Officer	Sale at price 2.10 per share.	Indirect	12 545	21 nov. 2022	5 960
HALL JUSTIN M Chief Executive Officer	Purchase at price 0.15 per share.	Direct	1 500	14 sept. 2022	10 000
KUNIN JEFFREY Officer	Sale at price 0.16 per share.	Indirect	46 094	14 sept. 2022	291 368
KUNIN AUDREY Officer and Director	Sale at price 0.16 per share.	Indirect	46 094	14 sept. 2022	291 368
FREIMAN PAUL EDWARD Director		Direct		20 mai 2022	30 000
ZHENG JEFF YENYOU Director		Direct		20 mai 2022	30 000
WU MIJIA Director		Direct		20 mai 2022	30 000
SIT SWAN Director		Direct		20 mai 2022	30 000
HALL JUSTIN M Chief Executive Officer	Purchase at price 0.43 per share.	Direct	30 000	06 déc. 2021	69 767
JONES ANDREW D. Chief Financial Officer	Purchase at price 0.01 per share.	Direct	554	06 déc. 2021	45 455
KUNIN JEFFREY Officer	Purchase at price 0.46 per share.	Indirect	47 013	03 déc. 2021	101 650
KUNIN AUDREY Officer	Purchase at price 0.46 per share.	Indirect	47 013	03 déc. 2021	101 650
KUNIN JEFFREY Officer	Purchase at price 0.48 per share.	Indirect	124 888	02 déc. 2021	262 369
KUNIN AUDREY Officer	Purchase at price 0.48 per share.	Indirect	124 888	02 déc. 2021	262 369
KUNIN JEFFREY Officer	Purchase at price 0.49 per share.	Indirect	7 276	01 déc. 2021	14 848
KUNIN AUDREY Officer	Purchase at price 0.49 per share.	Indirect	7 276	01 déc. 2021	14 848
KUNIN JEFFREY Officer	Purchase at price 0.46 per share.	Indirect	13 800	30 nov. 2021	30 000
KUNIN AUDREY Officer	Purchase at price 0.46 per share.	Indirect	13 800	30 nov. 2021	30 000
KUNIN JEFFREY Officer	Purchase at price 0.46 per share.	Indirect	41 868	23 nov. 2021	91 133
KUNIN AUDREY Officer	Purchase at price 0.46 per share.	Indirect	41 868	23 nov. 2021	91 133
WU MIJIA Director	Stock Award(Grant) at price 0.30 per share.	Direct	6 000	17 août 2020	20 000
WU MIJIA Director	Sale at price 1.35 per share.	Direct	27 000	17 août 2020	20 000
WU MIJIA Director	Conversion of Exercise of derivative security at price 56.70 per share.	Direct	1 134 000	17 août 2020	20 000
FU JIAN PING Beneficial Owner of more than 10% of a Class of Security	Sale at price 1.23 per share.	Direct	1 601 890	31 juil. 2020	1 302 350
SIECZKAREK MARK M. Former		Direct		30 juil. 2019	167 938
PIONEER PHARMA HONG KONG CO., LTD. Beneficial Owner of more than 10% of a Class of Security	Sale at price 4.04 per share.	Direct	98 277	11 juin 2019	24 326
WU MIJIA Director	Sale at price 2.03 - 4.04 per share.	Indirect	160 793	11 juin 2019	63 492
FU JIAN PING Beneficial Owner of more than 10% of a Class of Security	Sale at price 3.84 per share.	Direct	1 462 863	11 juin 2019	380 954
RALEIGH JASON PHILIP Chief Financial Officer	Sale at price 3.00 - 3.75 per share.	Direct	106 778	11 juin 2019	33 155
RALEIGH JASON PHILIP Chief Financial Officer	Conversion of Exercise of derivative security at price 2.20 - 2.35 per share.	Direct	74 404	11 juin 2019	33 155
HALL JUSTIN M Chief Executive Officer	Stock Award(Grant) at price 3.10 per share.	Direct	147 250	10 juin 2019	47 500
HALL JUSTIN M Chief Executive Officer	Sale at price 3.03 per share.	Direct	143 925	10 juin 2019	47 500
HALL JUSTIN M Chief Executive Officer	Conversion of Exercise of derivative security at price 2.02 per share.	Direct	95 950	10 juin 2019	47 500
HALL JUSTIN M General Counsel	Conversion of Exercise of derivative security at price 3.10 per share.	Direct	147 250	10 juin 2019	47 500
RALEIGH JASON PHILIP Chief Financial Officer	Conversion of Exercise of derivative security at price 3.10 per share.	Direct	72 556	10 juin 2019	23 405
HALL JUSTIN M General Counsel	Conversion of Exercise of derivative security at price 2.78 per share.	Direct	55 600	18 sept. 2017	20 000
FU JIAN PING Beneficial Owner of more than 10% of a Class of Security	Conversion of Exercise of derivative security at price 3.15 per share.	Direct	400 003	11 oct. 2016	126 985
SIECZKAREK MARK M. Chief Executive Officer	Conversion of Exercise of derivative security at price 1.91 per share.	Direct	522 284	30 sept. 2016	273 447
WU MIJIA Director	Conversion of Exercise of derivative security at price 3.15 per share.	Direct	50 000	30 sept. 2016	15 873
PIONEER PHARMA SINGAPORE PTE LTD Beneficial Owner of more than 10% of a Class of Security	Conversion of Exercise of derivative security at price 1.81 per share.	Direct	328 153	22 sept. 2016	181 300
PIONEER PHARMA SINGAPORE PTE LTD Beneficial Owner of more than 10% of a Class of Security	Conversion of Exercise of derivative security at price 1.91 per share.	Direct	2 500 003	22 sept. 2016	1 308 902
FU JIAN PING Beneficial Owner of more than 10% of a Class of Security	Conversion of Exercise of derivative security at price 1.91 per share.	Direct	1 850 001	22 sept. 2016	968 587
SIECZKAREK MARK M. Chief Executive Officer	Stock Award(Grant) at price 1.91 per share.	Direct	500 000	01 août 2016	261 780
PIONEER PHARMA SINGAPORE PTE LTD Beneficial Owner of more than 10% of a Class of Security	Stock Award(Grant) at price 1.91 per share.	Direct	2 500 001	01 août 2016	1 308 901
SIECZKAREK MARK M. Director	Stock Award(Grant) at price 1.91 per share.	Direct	500 000	09 mai 2016	261 780
PIONEER PHARMA SINGAPORE PTE LTD Beneficial Owner of more than 10% of a Class of Security	Stock Award(Grant) at price 1.91 per share.	Direct	2 500 001	09 mai 2016	1 308 901
FU JIAN PING Beneficial Owner of more than 10% of a Class of Security	Stock Award(Grant) at price 1.91 per share.	Direct	3 700 000	09 mai 2016	1 937 173
SIECZKAREK MARK M. Director	Stock Award(Grant) at price 1.91 per share.	Direct	239 489	25 févr. 2016	125 387
PIONEER PHARMA SINGAPORE PTE LTD Beneficial Owner of more than 10% of a Class of Security	Stock Award(Grant) at price 1.91 per share.	Direct	1 330 487	25 févr. 2016	696 590
NAJAFI RAMIN Chief Executive Officer	Purchase at price 0.44 - 0.50 per share.	Indirect	5 640	20 août 2015	12 000
HOON RUSSELL A Officer		Direct		14 avr. 2015	4 515
PAULSON THOMAS J Chief Financial Officer	Stock Award(Grant) at price 0.00 per share.	Direct	0	23 mars 2015	23 986
WU ROY J Officer	Stock Award(Grant) at price 0.00 per share.	Direct	0	23 mars 2015	19 296
NAJAFI RAMIN Chief Executive Officer	Stock Award(Grant) at price 0.00 per share.	Indirect	0	23 mars 2015	46 033
SIECZKAREK MARK M. Director	Purchase at price 0.60 per share.	Direct	100 000	03 mars 2015	166 666
NAJAFI RAMIN Chief Executive Officer	Purchase at price 0.60 per share.	Indirect	100 000	03 mars 2015	166 666
PIONEER PHARMA SINGAPORE PTE LTD Beneficial Owner of more than 10% of a Class of Security	Purchase at price 0.60 per share.	Direct	1 554 000	03 mars 2015	2 590 000
PAULSON THOMAS J Chief Financial Officer	Purchase at price 0.68 per share.	Direct	6 800	12 déc. 2014	10 000
NAJAFI RAMIN Chief Executive Officer	Purchase at price 0.65 per share.	Direct	32 500	12 déc. 2014	50 000
STROMAN DAVID W Officer	Purchase at price 0.66 per share.	Direct	6 600	12 déc. 2014	10 000
NAJAFI RAMIN Chief Executive Officer	Purchase at price 0.60 per share.	Direct	12 000	11 déc. 2014	20 000
PAULSON THOMAS J Chief Financial Officer	Purchase at price 0.67 per share.	Direct	6 700	09 déc. 2014	10 000
NAJAFI RAMIN Chief Executive Officer	Purchase at price 0.65 per share.	Direct	16 250	05 déc. 2014	25 000
WICKS TONY D S Director	Sale at price 0.70 per share.	Direct	14 000	02 déc. 2014	20 000
NAJAFI RAMIN Chief Executive Officer	Purchase at price 0.71 per share.	Direct	12 780	02 déc. 2014	18 000
WICKS TONY D S Director	Sale at price 0.69 per share.	Direct	6 900	01 déc. 2014	10 000
SIECZKAREK MARK M. Director	Purchase at price 0.89 per share.	Direct	4 272	04 juin 2014	4 800
NAJAFI RAMIN Chief Executive Officer	Stock Gift at price 0.00 per share.	Indirect	0	02 juin 2014	5 500
SIECZKAREK MARK M. Director	Purchase at price 0.88 per share.	Direct	22 000	19 mai 2014	25 000
CHINA PIONEER PHARMA HOLDINGS, LTD. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 0.99 per share.	Direct	64 414	13 mai 2014	65 065
CHINA PIONEER PHARMA HOLDINGS, LTD. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 0.99 per share.	Direct	114 946	12 mai 2014	116 107
CHINA PIONEER PHARMA HOLDINGS, LTD. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 0.99 per share.	Direct	315 640	09 mai 2014	318 828
WICKS TONY D S Director	Conversion of Exercise of derivative security at price 0.56 per share.	Direct	29 120	14 avr. 2014	52 000
DAILLEY ANTHONY Director	Conversion of Exercise of derivative security at price 0.56 per share.	Direct	5 040	17 mars 2014	9 000
PIONEER PHARMA SINGAPORE PTE LTD Beneficial Owner of more than 10% of a Class of Security	Purchase at price 1.14 per share.	Direct	5 700 000	02 déc. 2013	5 000 000
CHINA PIONEER PHARMA HOLDINGS, LTD. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 1.14 per share.	Indirect	5 700 000	02 déc. 2013	5 000 000
PIONEER PHARMA HONG KONG CO., LTD. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 1.14 per share.	Indirect	5 700 000	02 déc. 2013	5 000 000
CHINA PIONEER PHARMA HOLDINGS, LTD. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 1.02 per share.	Direct	110 319	14 nov. 2013	108 156
LI XINZHOU Beneficial Owner of more than 10% of a Class of Security	Sale at price 0.08 per share.	Direct	9 312	20 sept. 2013	120 000
LI XINZHOU Officer of Subsidiary Company	Purchase at price 1.20 per share.	Direct	144 000	11 déc. 2012	120 000
PAULSON THOMAS J Chief Financial Officer	Purchase at price 1.24 per share.	Direct	12 400	06 déc. 2012	10 000
NAJAFI RAMIN Chief Executive Officer	Purchase at price 1.24 per share.	Direct	24 800	06 déc. 2012	20 000
STROMAN DAVID W Officer	Purchase at price 1.24 per share.	Direct	12 400	06 déc. 2012	10 000
PIONEER PHARMA SINGAPORE PTE LTD Beneficial Owner of more than 10% of a Class of Security	Purchase at price 1.25 per share.	Direct	1 500 000	31 oct. 2012	1 200 000
NAQU AREA PIONEER PHARMA CO LTD Beneficial Owner of more than 10% of a Class of Security	Purchase at price 1.25 per share.	Indirect	1 500 000	31 oct. 2012	1 200 000
LI XINZHOU Beneficial Owner of more than 10% of a Class of Security	Purchase at price 1.25 per share.	Indirect	1 500 000	31 oct. 2012	1 200 000
TUFTS ROBERT R Director	Conversion of Exercise of derivative security at price 0.56 per share.	Indirect	15 960	27 sept. 2012	28 500
LI XINZHOU Beneficial Owner of more than 10% of a Class of Security	Purchase at price 1.25 per share.	Indirect	1 000 000	13 sept. 2012	800 000
PAULSON THOMAS J Chief Financial Officer	Purchase at price 0.94 per share.	Direct	9 364	30 mai 2012	10 000
NAJAFI RAMIN Chief Executive Officer	Purchase at price 0.96 per share.	Direct	5 756	29 mai 2012	6 000
NAJAFI RAMIN Chief Executive Officer	Purchase at price 0.99 per share.	Direct	3 465	25 mai 2012	3 500
FREIMAN PAUL EDWARD Director	Conversion of Exercise of derivative security at price 0.20 per share.	Indirect	6 000	29 déc. 2011	30 000
NAJAFI RAMIN Chief Executive Officer	Stock Award(Grant) at price 1.09 per share.	Direct	54 500	27 oct. 2011	50 000
NAJAFI RAMIN Chief Executive Officer	Stock Award(Grant) at price 0.90 per share.	Direct	137 406	29 sept. 2011	152 673
FREIMAN PAUL EDWARD Director	Purchase at price 0.84 per share.	Indirect	2 520	12 sept. 2011	3 000
PAULSON THOMAS J Chief Financial Officer	Purchase at price 0.86 per share.	Direct	3 010	26 août 2011	3 500
NAJAFI RAMIN Chief Executive Officer	Purchase at price 0.85 per share.	Direct	8 500	16 août 2011	10 000
TUFTS ROBERT R Director	Purchase at price 0.85 per share.	Indirect	4 242	15 août 2011	5 000
STROMAN DAVID W Officer	Purchase at price 1.01 per share.	Direct	10 100	16 juin 2011	10 000
KHOSROVI BEHZAD Officer	Purchase at price 1.63 - 1.65 per share.	Direct	1 644	27 mai 2011	1 000
NAJAFI RAMIN Chief Executive Officer	Purchase at price 1.59 per share.	Direct	797	27 mai 2011	500
MCPHERSON T ALEX Director	Purchase at price 1.63 - 1.65 per share.	Indirect	10 217	27 mai 2011	6 200
NAJAFI RAMIN Chief Executive Officer	Purchase at price 1.60 per share.	Direct	1 597	26 mai 2011	1 000
NAJAFI RAMIN Chief Executive Officer	Purchase at price 1.67 - 1.74 per share.	Direct	4 371	24 mai 2011	2 552
FREIMAN PAUL EDWARD Director	Sale at price 1.83 per share.	Indirect	27 450	16 août 2010	15 000
TUFTS ROBERT R Director	Conversion of Exercise of derivative security at price 2.02 per share.	Direct	36 679	04 janv. 2010	18 158
TUFTS ROBERT R Director	Stock Award(Grant) at price 0.00 per share.	Indirect	0	10 déc. 2009	302
DAILLEY ANTHONY Director	Stock Award(Grant) at price 0.00 per share.	Indirect	0	10 déc. 2009	302
MCPHERSON T ALEX Director	Stock Award(Grant) at price 0.00 per share.	Direct	0	10 déc. 2009	603
HIXSON HARRY F JR Director	Stock Award(Grant) at price 0.00 per share.	Indirect	0	06 oct. 2009	343
FREIMAN PAUL EDWARD Director	Stock Award(Grant) at price 0.00 per share.	Indirect	0	06 oct. 2009	343
FREIMAN PAUL EDWARD Director	Stock Award(Grant) at price 0.00 per share.	Indirect	0	06 oct. 2009	343
TUFTS ROBERT R Director	Stock Award(Grant) at price 0.00 per share.	Indirect	0	06 oct. 2009	343
DAILLEY ANTHONY Director	Stock Award(Grant) at price 0.00 per share.	Indirect	0	06 oct. 2009	686
MCPHERSON T ALEX Director	Stock Award(Grant) at price 0.00 per share.	Direct	0	06 oct. 2009	686
HIXSON HARRY F JR Director	Stock Award(Grant) at price 0.00 per share.	Indirect	0	15 sept. 2009	1 459
HIXSON HARRY F JR Director	Stock Award(Grant) at price 0.00 per share.	Indirect	0	14 sept. 2009	1 350
CASHION CHARLES J Director	Stock Award(Grant) at price 0.00 per share.	Indirect	0	14 sept. 2009	1 350
FREIMAN PAUL EDWARD Director	Stock Award(Grant) at price 0.00 per share.	Indirect	0	14 sept. 2009	1 350
WICKS TONY D S Director	Stock Award(Grant) at price 0.00 per share.	Indirect	0	14 sept. 2009	1 350
TUFTS ROBERT R Director	Stock Award(Grant) at price 0.00 per share.	Indirect	0	14 sept. 2009	1 350
DAILLEY ANTHONY Director	Stock Award(Grant) at price 0.00 per share.	Indirect	0	14 sept. 2009	1 350
MCPHERSON T ALEX Director	Stock Award(Grant) at price 0.00 per share.	Direct	0	14 sept. 2009	1 350
DAILLEY ANTHONY Director	Conversion of Exercise of derivative security at price 0.56 per share.	Indirect	5 600	03 sept. 2009	10 000
CASHION CHARLES J Director	Purchase at price 1.90 per share.	Indirect	1 900	31 août 2009	1 000
TUFTS ROBERT R Director	Conversion of Exercise of derivative security at price 0.56 per share.	Indirect	11 200	31 août 2009	20 000
CASHION CHARLES J Director	Stock Award(Grant) at price 0.00 per share.	Indirect	0	28 août 2009	1 428
FREIMAN PAUL EDWARD Director	Stock Award(Grant) at price 0.00 per share.	Indirect	0	28 août 2009	1 428
WICKS TONY D S Director	Stock Award(Grant) at price 0.00 per share.	Indirect	0	28 août 2009	1 428
NAJAFI RAMIN Chief Executive Officer	Purchase at price 1.92 per share.	Direct	1 920	28 août 2009	1 000
TUFTS ROBERT R Director	Stock Award(Grant) at price 0.00 per share.	Indirect	0	28 août 2009	1 428
DAILLEY ANTHONY Director	Stock Award(Grant) at price 0.00 per share.	Indirect	0	28 août 2009	1 428
MCPHERSON T ALEX Director	Stock Award(Grant) at price 0.00 per share.	Direct	0	28 août 2009	1 428
HIXSON HARRY F JR Director	Stock Award(Grant) at price 0.00 per share.	Indirect	0	13 août 2009	252
CASHION CHARLES J Director	Stock Award(Grant) at price 0.00 per share.	Indirect	0	13 août 2009	504
TUFTS ROBERT R Director	Stock Award(Grant) at price 0.00 per share.	Indirect	0	13 août 2009	252
HIXSON HARRY F JR Director	Purchase at price 2.33 per share.	Indirect	58 250	11 juin 2009	25 000
FREIMAN PAUL EDWARD Director	Sale at price 2.33 per share.	Indirect	58 250	11 juin 2009	25 000
HIXSON HARRY F JR Director	Stock Award(Grant) at price 0.00 per share.	Indirect	0	04 juin 2009	1 369

Dow Jones38 084,61-301,48(-0,79 %)

Nasdaq 15 860,03-123,06(-0,77 %)

Nikkei 22538 405,66+470,90(+1,24 %)

EUR/USD1,0683-0,0042(-0,40 %)

HANG SENG17 763,03+16,12(+0,09 %)

Bitcoin EUR58 726,11-631,68(-1,06 %)

NovaBay Pharmaceuticals, Inc. (NBY)

Transactions d’initiés

Transactions d’initiés rapportées - Deux dernières années

Dow Jones
38 084,61
-301,48(-0,79 %)

Nasdaq
15 860,03
-123,06(-0,77 %)

Nikkei 225
38 405,66
+470,90(+1,24 %)

EUR/USD
1,0683
-0,0042(-0,40 %)

HANG SENG
17 763,03
+16,12(+0,09 %)

Bitcoin EUR
58 726,11
-631,68(-1,06 %)